Systematic Review of the Trajectory Patterns of Distress Over the Cancer Continuum Among People Living with Cancer in the United States
Article Sidebar
Downloads
Submit your own article
Register as an author to reserve your spot in the next issue of the Medical Research Archives.
Author RegistrationJoin the Society
The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.
Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.
MembershipMain Article Content
Abstract
Purpose: Recommendations have been made for distress screening for all newly diagnosed cancer patients at their initial consult and along the cancer continuum. This review aims to synthesize the literature presenting distress trajectories of people living with cancer by describing distress trajectories by cancer site, assessment in the cancer continuum, by sex, and by instruments used.
Methods: A systematic review identified 5,792 quantitative studies that included distress trajectories associated with people living with cancer. Databases searched included Ovid-Medline, Scopus, PubMed, Web of Science, JSTOR, ScienceDirect, Wiley Interscience, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsycINFO. Data from 20 studies were extracted and summarized.
Results: Among the 20 studies, the five trajectory types described are low remaining low, low worsening to clinically high, recovery (low to high and back down to low), clinically high improving to low, and clinically high remaining clinically high. Of the 1,625 people living with cancer, 16% (262 people living with cancer) had trajectories with distress measuring high on their final outcome measure. Only 9 out of 20 studies described the distress trajectory over the full cancer continuum, from diagnosis through treatment and into follow-up care.
Conclusion: To advance current knowledge on ideal intervention times for clinicians in efficiently addressing distress among people living with cancer, distress measures collected throughout the cancer continuum for individual cancers are needed.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Kirsh KL, Passik SD. Assessment and treatment of psychosocial distress across the continuum. Rehabilitation Oncology. 2002;20(3):22-31.
3. Nikbakhsh N, Moudi S, Abbasian S, Khafri S. Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med. 2014;5(3):167-170.
4. Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):943. doi:10.1186/s12885-019-6181-4
5. National Comprehensive Cancer Network. NCCN Guidelines for Patients: Distress. Fort Washington PA: National Comprehensive Cancer Network; 1999.
6. National Comprehensive Cancer Network. NCCN Guidelines: Supportive Care. Published 2023. Accessed December 10, 2023. https://www.nccn.org/guidelines/category_3
7. National Comprehensive Cancer Network. NCCN Guidelines for Patients: Distress, Version 1.2024. National Comprehensive Cancer Network. Published 2024. Accessed January 3, 2024. https://www.nccn.org/docs/default-source/patient-resources/nccn_distress_thermometer.pdf
8. Holland JC, Bultz BD, National Comprehensive Cancer Network. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw. 2007;5(1):3-7.
9. Carlson LE. Psychosocial and integrative oncology: interventions across the disease trajectory. Annu Rev Psychol. 2023;74:457-487. doi:10.1146/annurev-psych-032620-031757
10. Barre PV, Padmaja G, Rana S, Tiamongla. Stress and quality of life in cancer patients: medical and psychological intervention. Indian J Psychol Med. 2018;40(3):232-238. doi:10.4103/ijpsym.Ijpsym_512_17
11. Andersen BL, Lacchetti C, Ashing K, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023;41(18):3426-3453. doi:10.1200/jco.23.00293
12. Ziegler L, Hill K, Neilly L, et al. Identifying psychological distress at key stages of the cancer illness trajectory: a systematic review of validated self-report measures. J Pain Symptom Manage. 2011;41(3):619-636. doi:10.1016/j.jpainsymman.2010.06.024
13. Hess CB, Singer M, Khaku A, et al. Optimal frequency of psychosocial distress screening in radiation oncology. J Oncol Pract. 2015;11(4):298-302.
doi:10.1200/JOP.2014.003392
14. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
15. Cutillo A, O'Hea E, Person S, et al. The Distress Thermometer: cutoff points and clinical use. Oncol Nurs Forum. 2017;44(3):329-336. doi:10.1188/17.ONF.329-336
16. Reid TR. The Healing of America: A global quest for better, cheaper, and fairer health care. London: Penguin Books; 2010.
17. National Heart Lung and Blood Institute. Study Quality Assessment Tools. National Institutes of Health. Published 2021. Accessed March 15, 2023.
https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
18. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2):377-381. doi:10.1016/j.jbi.2008.08.010
19. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Systematic Reviews. 2016;5:210. doi:10.1186/s13643-016-0384-4
20. Liang MI, Summerlin SS, Blanchard CT, et al. Measuring financial distress and quality of life over time in patients with gynecologic cancer-making the case to screen early in the treatment course. JCO Oncol Pract. 2021; 17(10):e1576-e1583. doi:10.1200/op.20.00907
21. Von Ah D, Kang D-H. Correlates of mood disturbance in women with breast cancer: patterns over time. J Adv Nurs. 2008;61(6): 676-689. doi:10.1111/j.1365-2648.2007.04563.x
22. Northouse LL, Templin T, Mood D, Oberst M. Couples' adjustment to breast cancer and benign breast disease: a longitudinal analysis. Psychooncology. 1998;7(1):37-48.
doi:10.1002/(SICI)1099-1611(199801/02)7:1<37 ::AID-PON314>3.0.CO;2-#
23. Trask PC, Paterson AG, Fardig J, Smith DC. Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: Results of a pilot study. Psychooncology. 2003;12(8):814-820. doi:10.1002/pon.703
24. Junghaenel DU, Cohen J, Schneider S, Neerukonda AR, Broderick JE. Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy. Support Care Cancer. 2015;23(9):2579-2587. doi:10.1007/s00520-015-2616-x
25. Madison AA, Peng J, Shrout MR, et al. Distress trajectories in black and white breast cancer survivors: from diagnosis to survivorship. Psychoneuroendocrino. 2021;131:105288. doi:10.1016/j.psyneuen.2021.105288
26. Rabin C, Leventhal H, Goodin S. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychology. 2004;23(4):407-412. doi:10.1037/t03589-000
27. Stanton AL, Snider PR. Coping with a breast cancer diagnosis: a prospective study. Health Psychol. 1993;12(1):16-23. doi:10.1037//0278-6133.12.1.16
28. Sanford SD, Beaumont JL, Butt Z, et al. Prospective longitudinal evaluation of a symptom cluster in breast cancer. J Pain Symptom Manage. 2014;47(4):721-730. doi:10.1016/j.jpainsymman.2013.05.010
29. Bailey Jr DE, Kazer MW, Polascik TJ, Robertson C. Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer. Oncol Nurs Forum. 2014;41(4):361-368. doi:10.1188/14.ONF.361-368
30. Kornblith AB, Powell M, Regan MM, et al. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007;16(10):895-903. doi:10.1002/pon.1146
31. Danhauer SC, Russell GB, Tedeschi RG, et al. A longitudinal investigation of posttraumatic growth in adult patients undergoing treatment for acute leukemia. J Clin Psychol Med Settings. 2013;20(1):13-24. doi:10.1007/s10880-012-9304-5
32. Ames SC, Parker AS, Crook JE, et al. Quality of life of patients undergoing surgical treatment for newly-diagnosed, clinically localized renal cell carcinoma. J Psychosoc Oncol. 2011;29(6):593-605.
doi:10.1080/07347332.2011.616574
33. El-Jawahri A, Abel GA, Traeger L, et al. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy. Leukemia. 2019;33(10):2393-2402.
doi:10.1038/s41375-019-0449-1
34. Krischer MM, Xu P. Determinants of psychological functioning in patients undergoing radiotherapy: a descriptive study. J Psychosoc Oncol. 2008;26(4):1-13. doi:10.1080/07347330802359552
35. Adamowicz JL, Christensen A, Howren MB, et al. Health-related quality of life in head and neck cancer survivors: Evaluating the rural disadvantage. J Rural Health. 2022;38(1):54-62. doi:10.1111/jrh.12571
36. Chen AM, Jennelle RL, Grady V, et al. Prospective study of psychosocial distress among patients undergoing radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2009;73(1):187-193.
doi:10.1016/j.ijrobp.2008.04.010
37. McQuellon RP, Russell GB, Rambo TD, et al. Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marrow Transplant. 1998;21(5):477-486. doi:10.1038/sj.bmt.1701115
38. Albrecht TA, Boyiadzis M, Elswick Jr RK, Starkweather A, Rosenzweig M. Symptom management and psychosocial needs of adults with acute myeloid leukemia during induction treatment: a pilot study. Cancer Nurs. 2017;40(6):E31-E38. doi:10.1097/NCC.0000000000000428
39. Stommel M, Kurtz ME, Kurtz JC, Given CW, Given BA. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 2004;23(6):564-573. doi:10.1037/0278-6133.23.6.564